|
|
|
● |
|
|
 |
| |
| |
 |
| |
|
| |
Tuesday, 11/13/07
Posted 11/13/07, 09:31
pm |
(Scroll down to see Jim's
comments below) |
|
| |
| |
|
Today's date:
Tuesday, 11/13/07 |
|
| |
Dow Jones: |
13,307 |
+319 |
| |
NASDAQ: |
|
2,673 |
+89 |
| |
S&P 500: |
|
1,481 |
+41 |
| |
|
| |
|
| |
|
Final Segment 1
Title: |
'Lesson Learned' |
|
. . . .
. |
|
Featured Stock(s): |
Onyx
Pharmaceuticals Inc. (ONXX)
See 2nd segment picks
below...
|
|
JJC:
Tough to ever think
negative on an up-300
point day but, just as
it's hard to think
positive on a down-300
day, we're going to
imagine how things may not
pan out...
So, when you think of
2008, you probably don't
imagine a bright year for
the economy, or a bright
year for the market.
I have been saying that we
need to be worried about a
1990 situation, where real
estate carries us down...
We're going to be thinking
of what made money in
1990, when the Fed didn't
come to the rescue in
time, and the averages
were down double digits...
What worked then were some
pharma, some
indestructibles... and
biotech...
And a lot of the
highest-growing biotech
stocks did the best and,
by far, the best, in 1990,
was Amgen (AMGN)...
Now, I've told you I'd
think about Celgene
Corporation (CELG)
and, to a lesser extent,
Genentech Inc. (DNA)...
I think those are really
good stocks for 2008.
They fit the 1990
playbook...
I'm flipping through, and
sure enough... well, I
can't show it to you
yet...
AMGN was the
highest-growth stock in
1990, and so people made a
lot of money, even though
it was the highest risk
stock in 1990... and that
means, in 2008, we're
going to find the next
AMGN, and that is Onyx
Pharmaceuticals Inc. (ONXX)...
That's our AMGN for
2008...
. . . .
.
. . . .
.
The Bottom Line!:
It's going to
become increasingly clear that every
portfolio must have a high-growth
biotech stock in this market, as the
U.S. economy decelerates. I choose
Onyx Pharmaceuticals Inc. (ONXX),
but Celgene Corporation (CELG)
and Genentech Inc. (DNA)
are good for the more cautious of you.
Take your pick.
|
|
 |
 |
|
|
|
|
|
|
|
|
|
 |
|
See all of tonight's stocks'
latest quotes on
Yahoo! Finance |
|
Most popular
investing books ordered:
(click any book to see at
Amazon.com)
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
We need your help!
If you find our service valuable, your
donation is critically helpful to support
our operating costs and is
MUCH appreciated!
(click below to donate) |
We are serving thousands
of
new visitors every day and our costs are
growing as well. Thank you for your
support & generosity!
|
|
|
|
|
| |
| |
|
| |
|
■ |
Stock Snapshots - Includes
all stocks mentioned above |
■ |
|
| |
|
| |
|
Jim
Cramer's
rating on
this stock |
STOCK
SYMBOL |
Closing
price
that
day |
Opening
price
next
day |
Full Company
Name/Comments
(see comments above for
each) |
|
 |
ONXX |
58.70 |
60.55 |
Onyx
Pharmaceuticals Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Final Segment
2 Title: |
'Mad Mail'
Jim takes
selected mail
that he receives
and answers some
viewers'
questions...
See them below. |
|
. . . .
. |
|
Featured
Stock(s): |
Pepsico, Inc.
(PEP)
Altria Group Inc.
(MO*)
Coca Cola
(KO)
Nastech
Pharmaceutical
Company (NSTK) |
|
|
Jim
Cramer's
rating on
this stock |
STOCK
SYMBOL |
Closing
price
that
day |
Opening
price
next
day |
Full Company
Name/Comments
(see comments above for
each) |
|
|
PEP |
73.34 |
73.90 |
Mad Mail
Pepsico, Inc.
Q:
Lately you've
mentioned picking up
the "indestructible"
stocks, like
Altria Group Inc.
(MO*),
and Coca-Cola Co.
(KO),
but I haven't heard
any mention on PEP.
Has PEP fallen out
of favor in
Cramerica, or are KO
and MO* the
best-of-breed you
want as we head
toward a possible
recession?
JJC:
You know, there's a
reason why I have
been more concerned
about PEP...
PEP is fine... PEP
is fine, but they
have a higher raw
cost. You see,
KO came on our show
when we were at
Georgia Tech, and
said that their
commodity costs have
peaked, and PEP
couldn't say that,
but PEP's doing a
darn good job.
I'm not bashing PEP
by any means.
It's just that KO
made that statement
on our show, and
I've been living
with that statement,
and MO*'s splitting
into two, so it's
got more going for
it. I own MO*
for
my charitable trust...
|
|
|
MO* |
72.85 |
73.15 |
Mad Mail
Altria Group Inc.
See PEP comments
above for:
MO*
|
|
|
KO |
61.04 |
61.30 |
Mad Mail
Coca-Cola Co.
See PEP comments
above for:
KO
|
|
|
NSTK |
4.87 |
5.13 |
Mad Mail
Nastech
Pharmaceutical
Company
Q:
Huge
baby-crying-Cramer-sound-board-effect
for Nastech (NSTK).
With the news of
Procter & Gamble
(PG) pulling out of
the PTH1-34 deal, I
developed a
curiosity around
these speculative
companies.
When one considers
buying into a spec,
should the weight of
revenue from the
partnerships of
bigger companies be
a strong factor?
In other words,
should we be more
cautious of those
companies relying on
a large percentage
of revenue or
general financial
stability coming
from the partnership
of a larger company
than those that rely
on revenue strictly
from its client
base?
JJC:
What attracted me to
NSTK was the Procter
relationship, and
when we had the guy
on - and when the
stock was at $12 -
did he give us any
sight that PG might
not want to be
involved?... The
fact that he didn't
know it is
irrelevant to me.
The fact that he
thought that PG
wanted to be
involved, to me,
just says how
dangerous the whole
thing was. It
was my bad. I
believed.
Whenever I believe,
I do get into a
little bit of
trouble, don't I?
It shows you you
have to be
skeptical... No
matter what, you
have to be
skeptical...
|
[
end of final segment ]
|
| |
|
| |
|
Go to the next segment from
tonight's show
here >>
See current quotes on Yahoo!
Finance from
tonight's show stocks
here >> |
|
|
|
Symbol keys: |
|
 |
A Charitable Trust stock.
- An asterisk next to a
stock symbol indicates that
Jim mentioned it is a stock
that he manages within
his
charitable trust portfolio.
You can see the complete
portfolio
of stocks
here >> |
|
| | | | |
